In this session Dr. Chopra, a world renowned hepatologist, thinker, inspirational speaker and bestselling author will simulate commonly posed curbside and email questions to a hepatologist from a primary care clinician. Please note that any data, indications, and guidelines presented in this activity are current as of the recording/release on February 9, 2020, and they are subject to change as new information is published.
Stay up to date with the latest USPSTF recommendations for screening and preventive interventions in primary care. Hear about important changes regarding which patients should be screened for colorectal cancer, lung cancer, and hepatitis C virus infection. Walk away from this session with a firm grasp of the evidence of benefits vs harms for each of these recommendations so that you and your patients are positioned to make the best decisions for their care.
Fatty liver has emerged as a major health concern in the United States. It is now one of the leading causes of cirrhosis, risk factor for liver cancer and indication for liver transplantation. This session will help clinicians to understand the epidemiology and risk factors of fatty liver as well as how to tailor medical care in patients with underlying fatty liver disease.
In this CE podcast, two experts discuss exciting changes in the treatment landscape for HCC and how primary care providers can help with follow-up and care coordination.
Two experts discuss HCC patient cases, examining the role of screening and referral in their disease course trajectory in this accredited CE podcast.
Although hepatocellular carcinoma (HCC) screening can improve survival for patients, it is underused in clinical practice. Tune in to this 3-part podcast series to listen to faculty experts address the urgency for early identification and improved care for HCC.
Guest: Robert Baldor, MD, FAAFP Music Credit: Richard Onorato
Heartburn is a frequent complaint in primary care practices. The etiology is broad, from reflux to H. pylori infection and PUD. While many clinicians treat symptomatically, this may not lead to patient satisfaction. A recent network meta-analysis published in The BMJ, concluded that a ‘test and treat’ approach resulted in the lowest reports for patients to remain symptomatic at follow-up.
Getting Glutened: Early Childhood Gluten Consumption and the Risk of Celiac Disease - Frankly Speaking EP 144
Guest: Alan Ehrlich MD, FAAFPMusic Credit: Richard Onorato
The degree to which early exposure to gluten-containing foods affects the risk of developing celiac disease is controversial. Join us as we discuss a recent Norwegian study suggesting that the timing of introduction of gluten in the diet may be less important than the amount of gluten in the diet at 18 months of age.
The COVID-19 pandemic has taken its toll not only on patients’ lungs but on their gastrointestinal systems and mental health as well. Drs. Shirah Vollmer and Neilanjan Nandi share practical answers to the top questions they frequently hear from other clinicians on COVID-19−related GI and anxiety disorders. Chances are, you have some of the same questions! Get the answers you need to steer your patients through this difficult time.
Cutting Through the Fog: Recognizing Gluten-Induced Neurocognitive Impairment - Frankly Speaking EP 242
Guest: Alan M. Ehrlich, MD, FAAFPMusic Credit: Richard Onorato
Gluten exposure is known to cause a number of problems in both those with celiac disease and those with non-celiac gluten sensitivity. One aspect that has not received much attention from the research community is the neurocognitive impairment that can occur following gluten exposure in these individuals. Join us for this podcast to dive into a recent article that describes these effects.